Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 23, 2020
Stocks to Watch as Election Day Approaches

Stocks to Watch as Election Day Approaches

Successful traders don’t think defensively. Each day is a new attack and outside noise like election results don’t typically affect us. Money is made and lost while riding the waves of volatility. The only charts that matter are the ones that show us stock patterns.

Investors need to think differently. We have a presidential election coming up in November. There are also a number or congressional and senate seats up for grabs. The results at the end of that day could change to outlook for some of your favorite long-term investments.

In this article, we’ve laid out a strategy to position investors for any outcome on election day. We’ve also included a few recommendations for stocks to buy when your candidate (or the other guy) gets elected. As always, use Tickeron to analyze these before buying. 

Stocks to Buy Regardless of Outcome

There are certain stocks that should rise regardless of who wins the election. Keep in mind that the vote is tallied on November 3rd, but the winning candidate will not take his oath of office until January. The market typically gets a bit bullish during that two-month waiting period.

In 2016, when Donald Trump beat Hillary Clinton, the S&P 500 jumped 6.4% in the sixty days immediately following election day. That’s not typical. The index has risen in seven of the past ten elections, but at an average rate of just 0.7%. In other words, don’t expect miracles.

Certain sectors will do better than others. If you’re looking for safe bet, go with the Industrial Select Sector SPDR ETF (XLI). The momentum indicator moved above zero on October 5th and the fund is up 5.33% already in the past month. This sector has been projected to do well. 

If you’re looking for an individual stock in the industrial sector, check out Rockwell Automation (ROK). The company is 117 years old and has outperformed the S&P after each of the past six elections. It’s an even safer bet this year. Their stock is up 23% already this year.

Energy stocks typically do well after an election, but this year could be different. The two candidates have very different views and policies on energy, with Biden pushing more for electrification and Trump still firmly behind petroleum-based energy.

If you must invest in the energy sector, look at Cabot Oil and Gas (COG). They’ve actually performed fairly well through the pandemic and are expected to report a 20% rise in earnings on October 29th. That should give you a boost going into election day.

To hedge your bets, buy an equal amount of Tesla (TSLA) when you buy Cabot. They recently came out of the overbought zone (which we predicted) and are expected to uptrend right on time for the election. Earnings are down, but the upside could be huge.    

Stocks to Buy if Trump Wins

Don’t believe the polls. The race is closer than it appears and either candidate can win. If Trump secures a second term, you can expect certain sectors to surge and others to maintain the steady growth they’ve achieved over the last four years. 

Analyzing how the election will affect the stock market begins with understanding how each camp is campaigning. Trump is a xenophobe, fanning the flames of distrust of the Chinese, blaming them for the pandemic in the United States. 

That paranoia creates a level of tension that fuels the defense industry, driving stock prices up in companies like Lockheed Martin (LMT) and Raytheon (RTX). Lockheed Martin is actually a good buy right now, since it’s down nearly 7% since the beginning of the year.

Trump is also a proponent of second amendment rights and believes all Americans should be able to purchase firearms. That could bode well for Smith and Wesson (SWBI) and Ruger Firearms (RGR), though both have been in downtrend for several months. 

As a political party, Republicans favor smaller government and fewer regulations. Industries that have benefited the most from this during the Trump administration include the energy sector and financial services firms. There are different ways to invest in each of these.

For the energy sector, take advantage of the last few years of oil and gas dominance if Trump gets reelected. We’ve already mentioned Cabot Oil and Gas (COG). Another good bet, at least in the short term, is United States Brent Oil (BNO). Tickeron’s AI shows an 86% chance of uptrend. 

In the financial sector, expect Wells Fargo (WFC) to rise back to prominence if Trump stays in office. They’ve seen some hard times recently after a phony account scandal but have restructured and are showing signs of life. We have them as a solid “buy” right now.

If you’re looking for a financial services ETF, take a look at the Financial Select Sector SPDR Fund (XLF). All of our signals show that it’s in uptrend and will continue there for several weeks. A republican sweep in the election could cause that trend to continue into next year.

Of course, none of this is guaranteed if there are additional shutdowns in the United States due to a Covid-19 second wave, but we’ll get into that further below. As always, we recommend you check your Tickeron Signals before buying anything and stay alert for unexpected changes. 

Stocks to Buy if Biden Wins

At no point in recent history have two presidential candidates been so far apart on business and economic issues. While Trump wants to remove regulations and obstacles to business expansion, Biden would prefer the government control more of that.

A good example of this is the Paris Accord, a climate change agreement that Trump pulled out of early in his first term. The rationale at that time was that it was cost-prohibitive to businesses to implement the environmental measures required by the agreement.

Biden wants to get the United States back into the Paris Accord and adopt the Green New Deal, an even more drastic climate change proposal that could seriously damage oil, gas, shale, and coal companies in the United States. This could cause a major disruption on Wall Street.

If Biden wins, we’ll likely see a sell-off of petroleum stocks and renewed investment in renewables and alternative energy. Tesla (TSLA), a leading manufacturer of electric vehicles, will prosper no matter who wins. A Biden victory would make them the best bet of the year.

It’s difficult to predict which renewable energy firms will benefit the most since none of them have a historical track record of long-term success. If you’re looking to invest in this sector, choosing an ETF and letting the market do the work for you might be the best option.

One of the renewable energy ETFs we’ve been watching at Tickeron is the iShares Global Clean Energy ETF (ICLN). It’s showed record-breaking daily volume in the past month, likely due to Biden being ahead in the polls. Our signals have it firmly in bull territory.

Another ETF in the renewable energy sector is the SPDR Kensho Clean Power ETF (CNRG). This is an interesting watch because we’re getting mixed signals on it. For much of the year, it was overbought, a condition it recently emerged from. A Biden win should make it go up again.

The Biden camp is also pushing for more money to be infused into the health care system and an increase in Covid-19 testing throughout the United States. There are a number of companies that could benefit from this, but it’s dependent on congressional approval.  

If additional testing and monitoring is approved by congress, look for Microsoft (MSFT) to be one of the beneficiaries of that. Bill Gates has been working on tracking technology that may go mainstream if the democrats take control in November.  

Winners in the Pandemic Policy Debate

Covid-19 is still out there and can alter any of the predictions we’ve made in this article. The way in which each candidate plans to handle pandemic response will cause multiple companies to either succeed or fail, particularly in the biotech industry.

Investing in biotech is a high risk/high reward proposition. The race for a Covid-19 vaccine has been an example of that. AstraZeneca (AZN) and Pfizer (PFE) were in the driver’s seat until they hit setbacks in clinical trials. Now they are in downtrend. 

Moderna (MRNA) is also in downtrend right now, but has shown more potential in recent months. They seem to be in the best position to produce a vaccine first. Does that make them a good investment? It’s impossible to answer that before the election.

Trump has been fast-tracking the FDA for approvals to get a vaccine out quickly. Biden has stated on many occasions that we don’t want to rush into anything. The winner of this election is literally holding the future of these biotech companies in his hand.

Prior to the election, we recommend only small investments in biotech. When it’s over, stick to short-term trading in the space. Some of these firms may look like long-term winners, but they are not. Returns in biotech are like shooting stars. They burn out quickly. 

Related Ticker: XLI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


XLI's Indicator enters downward trend

The Aroon Indicator for XLI entered a downward trend on September 18, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 121 similar instances where the Aroon Indicator formed such a pattern. In 101 of the 121 cases the stock moved lower. This puts the odds of a downward move at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XLI as a result. In 70 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

The Moving Average Convergence Divergence Histogram (MACD) for XLI turned negative on August 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 35 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

XLI moved below its 50-day moving average on August 20, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for XLI crossed bearishly below the 50-day moving average on August 27, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where XLI's RSI Indicator exited the oversold zone, 24 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLI advanced for three days, in 289 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

XLI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Caterpillar (NYSE:CAT), GE Aerospace (NYSE:GE), Deere & Company (NYSE:DE), Union Pacific Corp (NYSE:UNP), Boeing Company (NYSE:BA), Uber Technologies (NYSE:UBER), Lockheed Martin Corp (NYSE:LMT), CSX Corp (NASDAQ:CSX), Johnson Controls International plc (NYSE:JCI), 3M Company (NYSE:MMM).

Industry description

The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Industrial Select Sector Index. Under normal market conditions, the fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Industrial companies by the Global Industry Classification Standard, including securities of companies from the following industries: aerospace and defense; industrial conglomerates; marine transportation. It is non-diversified.

Market Cap

The average market capitalization across the State Street Industrial Select Sector SPDR ETF (XLI) ETF is 75.46B. The market cap for tickers in the group ranges from 6.25B to 371.87B. CAT holds the highest valuation in this group at 371.87B. The lowest valued company is BLDR at 6.25B.

High and low price notable news

The average weekly price growth across all stocks in the State Street Industrial Select Sector SPDR ETF (XLI) ETF was -2%. For the same ETF, the average monthly price growth was -7%, and the average quarterly price growth was 6%. GNRC experienced the highest price growth at 11%, while JBHT experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the State Street Industrial Select Sector SPDR ETF (XLI) ETF was 136%. For the same stocks of the ETF, the average monthly volume growth was 137% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 46
Price Growth Rating: 53
SMR Rating: 41
Profit Risk Rating: 56
Seasonality Score: -19 (-100 ... +100)
View a ticker or compare two or three
XLI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Industrials

Profile
Details
Category
Industrials
Address
One Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.